SCHEMBL6644155

SCHEMBL6644155

Cc1cc2c(cc1[N+](=O)[O-])NC(=O)C1CCCC21.O=C1Nc2cc([N+](=O)[O-])ccc2C2CCCC12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.43
NOS3 P29474 2/20 0.42
NOS1 P29475 2/20 0.42
NOS2 P35228 2/20 0.42
PGR P06401 1/20 0.38
TERT O14746 1/20 0.38
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 3/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
MEN1 O00255 2/20 0.36
ABCC8 Q09428 1/20 0.36
KCNJ11 Q14654 1/20 0.36
CHRNA7 P36544 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643002 0.91 MAPK1 (0.38) LMNAKMT2AGAANOS3NOS1
SCHEMBL6643026 0.88 NOS3 (0.51) LMNAKMT2AGAANOS3NOS1
SCHEMBL6641968 0.81 NOS3 (0.51) KMT2AGAANOS3NOS1NOS2
SCHEMBL6640660 0.77 MAPK1 (0.37) LMNAKMT2AGAANOS3NOS1
SCHEMBL6646342 0.74 NOS3 (0.50) LMNAKMT2AGAANOS3NOS1
SCHEMBL6642433 0.72 NOS3 (0.44) GAANOS3NOS1NOS2TSHR
SCHEMBL6643494 0.69 ALDH1A1 (0.37) KMT2ANOS3NOS1NOS2ALDH1A1
SCHEMBL6643304 0.67 NOS3 (0.50) LMNAKMT2AGAANOS3NOS1
SCHEMBL6645276 0.67 NOS3 (0.44) KMT2ANOS3NOS1NOS2MEN1
SCHEMBL6645803 0.67 NOS3 (0.44) KMT2ANOS3NOS1NOS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed